Catalyst Capital Advisors’s Hims & Hers Health HIMS Stock Holding History

Catalyst Capital Advisors’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-152,500	Closed	-$2.36M	–	406
2024 Q1	$2.36M	Sell	152,500 -233,720	-61%	-$2.64M	0.06%	108
2023 Q4	$3.44M	Sell	386,220 -40,500	-9%	-$299K	0.09%	82
2023 Q3	$2.68M	Buy	426,720 +68,500	+19%	+$509K	0.08%	98
2023 Q2	$3.37M	Buy	358,220 +6,300	+2%	+$62.5K	0.1%	89
2023 Q1	$3.49M	Sell	351,920 -99,000	-22%	-$868K	0.11%	84
2022 Q4	$2.89M	Hold	450,920	–	–	0.09%	95
2022 Q3	$2.52M	Hold	450,920	–	–	0.09%	100
2022 Q2	$2.04M	Buy	450,920 +330,920	+276%	+$1.41M	0.09%	117
2022 Q1	$640K	Buy	+120,000	New	+$594K	0.03%	178

Other funds holding HIMS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IVMX

Institutional Venture Management XVI Menlo Park, California $1.18M AUM 156.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Catalyst Capital Advisors's HIMS Position: Q2 2024 in Review

Catalyst Capital Advisors sold out of Hims & Hers Health (HIMS) in Q2 2024, closing a stake of 152,500 shares — an estimated $2.36M sold.

Catalyst Capital Advisors first reported a position in HIMS in Q1 2022 and held it in 9 quarters. The position peaked at $3.49M in Q1 2023. 297 funds tracked by Wall St. Rank hold HIMS as of Q2 2024.

Catalyst Capital Advisors reported no remaining Hims & Hers Health position as of Q2 2024 after selling out during the quarter.
Catalyst Capital Advisors sold 152,500 Hims & Hers Health shares in Q2 2024, an estimated $2.36M.
Catalyst Capital Advisors first reported a position in Hims & Hers Health in Q1 2022 and held it in 9 quarters.
Catalyst Capital Advisors's Hims & Hers Health position peaked at $3.49M in Q1 2023.
297 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2024.

Based on Catalyst Capital Advisors's 13F filing for Q2 2024, filed 25 Jul 2024.